Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$61.34
neg -0.50
-0.81%
Today's Range: 61.16 - 61.82 | MRK Avg Daily Volume: 8,255,100
Last Update: 08/18/17 - 10:53 AM EDT
Volume: 2,110,292
YTD Performance: 6.51%
Open: $61.77
Previous Close: $61.84
52 Week Range: $58.29 - $66.80
Oustanding Shares: 2,727,354,340
Market Cap: 171,005,117,118
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.73 1.73 1.73 1.73
Latest Dividend: 0.47
Latest Dividend Yield: 3.00%
Dividend Ex-Date: 09/14/17
Price Earnings Ratio: 33.89
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
33.89 34.10 36.20
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.71% -2.29% 6.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.80 -0.10 -0.03
Net Income -11.60 -0.10 -0.04
EPS -9.60 -0.10 -0.02
Earnings for MRK:
EBITDA 11.47B
Revenue 39.81B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.03 $0.95 $3.87 $4.17
Number of Analysts 7 6 9 9
High Estimate $1.07 $0.98 $3.88 $4.45
Low Estimate $0.99 $0.91 $3.85 $4.04
Prior Year $1.07 $0.89 $3.78 $3.87
Growth Rate (Year over Year) -3.60% 7.30% 2.26% 7.79%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Aug 17, 2017 | 4:23 PM EDT
There are plenty of reasons for the selloff, not the least of which is White House chaos.
By

James "Rev Shark" DePorre

 | Aug 15, 2017 | 7:24 AM EDT
The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.
By

Jim Cramer

 | Aug 14, 2017 | 3:14 PM EDT
Because the selloff isn't over.
RMPIA
By

Jim Cramer

 | Aug 7, 2017 | 2:17 PM EDT
What a difference 2 years make -- or 17.
RMPIA
By

Jim Cramer

 | Jul 28, 2017 | 11:30 AM EDT
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks.
By

Bruce Kamich

 | Jun 27, 2017 | 8:28 AM EDT
MRK has shaped up on the charts.
RMPIA
By

Jim Cramer

 | Jun 23, 2017 | 6:37 AM EDT
It just isn't as useful or descriptive right now.
By

Bret Jensen

 | Jun 7, 2017 | 10:00 AM EDT
Two are turnaround stories, and two are oversold.
RMPIA
By

Jim Cramer

 | May 18, 2017 | 3:31 PM EDT
Day 2 of the selloff brings in an entirely new kind of buyer.
By

Robert Moreno

 | May 8, 2017 | 1:00 PM EDT
The price momentum and money flow indicators of the drug maker are in positive alignment.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.